The healthcare industry continues to be a hotbed of innovation, with activity driven by telemedicine, real-time diagnostics, smart hospitals and access to digital therapies, and the growing importance of technologies such as artificial intelligence (AI), the internet of things (IoT), augmented reality (AR), robotics and data management practices. In the last three years alone, there have been over 106,000 patents filed and granted in the healthcare industry, according to GlobalData’s report on Genomics in Healthcare: Genome sequence analysis tools. Buy the report here.
According to GlobalData’s Technology Foresights, which uses over 443,000 patents to analyse innovation intensity for the healthcare industry, there are 200+ innovation areas that will shape the future of the industry.
Genome sequence analysis tools is a key innovation area in genomics
Genome sequencing data is analysed by a specific set of software, tools, and applications. Initially, the raw data generated from the sequencer is analysed for quality checks. Then, the data with good quality is subjected to downstream analysis.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 50+ companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of genome sequence analysis tools.
Key players in genome sequence analysis tools – a disruptive innovation in the healthcare industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to genome sequence analysis tools
|Company||Total patents (2010 - 2021)||Premium intelligence on the world's largest companies|
|Illumina||241||Unlock company profile|
|Laboratory Corp of America Holdings||64||Unlock company profile|
|Psomagen||55||Unlock company profile|
|NantWorks||54||Unlock company profile|
|Caris MPI||49||Unlock company profile|
|Sysmex||37||Unlock company profile|
|F. Hoffmann-La Roche||26||Unlock company profile|
|Natera||25||Unlock company profile|
|BioNTech||23||Unlock company profile|
|Worldwide Innovative Networking in personalized cancer medicine consortium||20||Unlock company profile|
|Five3 Genomics||20||Unlock company profile|
|Guardant Health||19||Unlock company profile|
|Myriad Genetics||15||Unlock company profile|
|Biora Therapeutics||15||Unlock company profile|
|Centre for Addiction and Mental Health||15||Unlock company profile|
|Koninklijke Philips||14||Unlock company profile|
|Celmatix||13||Unlock company profile|
|Merck & Co||13||Unlock company profile|
|BillionToOne||12||Unlock company profile|
|InVitae||12||Unlock company profile|
|Beijing BGI-GBI Biotech||12||Unlock company profile|
|Proove Biosciences||12||Unlock company profile|
|Siemens||11||Unlock company profile|
|Synaptamine||10||Unlock company profile|
|iRepertoire||10||Unlock company profile|
|Johnson & Johnson||10||Unlock company profile|
|Population Bio||10||Unlock company profile|
|Tata Sons||9||Unlock company profile|
|Assistance Publique - Hopitaux de Paris||9||Unlock company profile|
|OpGen||9||Unlock company profile|
|Cooper Companies||8||Unlock company profile|
|Annoroad Gene Technology||8||Unlock company profile|
|Cold Spring Harbor Laboratory||8||Unlock company profile|
|TALIAZ||8||Unlock company profile|
|SK Telecom||8||Unlock company profile|
|4D Pharma||7||Unlock company profile|
|Chang Gung Memorial Foundation||7||Unlock company profile|
|Vela Operations Singapore||7||Unlock company profile|
|Memorial Sloan Kettering Cancer Center||6||Unlock company profile|
|Macrogen||6||Unlock company profile|
|Yourgene Health||6||Unlock company profile|
|Nomi Health||6||Unlock company profile|
|Tempus Labs||5||Unlock company profile|
|BostonGene||5||Unlock company profile|
|miR Scientific||5||Unlock company profile|
|Guangzhou Burning Rock Dx||5||Unlock company profile|
|Cancer Research UK||5||Unlock company profile|
|Veracyte||5||Unlock company profile|
|Deep Genomics||5||Unlock company profile|
|Perfect (China)||5||Unlock company profile|
Source: GlobalData Patent Analytics
Illumina is one of the leading patent filers in the market for genome sequencing analysis tools. Some other key patent filers in the field include Psomagen and NantWorks. In terms of application diversity, Johnson & Johnson leads the pack, followed by 4D Pharma and Center for Addiction and Mental Health. By means of geographic reach, Synaptamine held the top position, followed by iRepertoire and BioNTech in second and third spots, respectively.
Functional genomic analysis has been carried out using a range of methods and methodologies for many years. High-throughput techniques, which range from conventional real-time polymerase chain reactions to more complicated systems, such as next-generation sequencing or mass spectrometry, have recently seen a quick dramatic advancement. There are several approaches and instruments available for doing proper functional analysis. Despite significant analytical advancement, these approaches have several limits. As a result, in order to push the boundaries of present approaches, several high-throughput technologies, such as quantitative real-time polymerase chain reaction, next-generation sequencing, or mass spectrometry, have been created, allowing for genome-wide functional investigation.
To further understand the key themes and technologies disrupting the healthcare industry, access GlobalData’s latest thematic research report on Healthcare.